Skip to main content

Silvia Amoretti Guadall

Graduated in Psychology at the Autonomous University of Barcelona, Master in Initiation to Research in Mental Health at the University of Barcelona and PhD in Biomedicine with international mention at the University of Barcelona.

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Silvia Amoretti Guadall

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Graduated in Psychology at the Autonomous University of Barcelona, Master in Initiation to Research in Mental Health at the University of Barcelona and PhD in Biomedicine with international mention at the University of Barcelona.

Postdoctoral researcher recipient of a Sara Borrell Contract (CD20/00177) at Vall d'Hebron Research Institute (VHIR). She develops her research activity in the research Group 27 of the Center for Biomedical Research in Mental Health Network (CIBERSAM). She is a collaborating professor in the Master's Degree in Initiation to Research in Mental Health and Master of Neurosciences at the University of Barcelona. She follows a line of research focused on cognitive reserve, neuropsychology and functioning of early psychotic episodes. She has 60 authored publications with a cumulative h-index of 13 (WOS).

Projects

Caracterización de los correlatos clínicos, neuropsicológicos, genéticos y de neuroimagen de los primeros episodios de manía.

IP: Silvia Amoretti Guadall
Collaborators: Judit Álvarez González
Funding agency: Instituto de Salud Carlos III
Funding: 41630
Reference: MV22/00002
Duration: 02/01/2023 - 16/01/2024

Disentangling clinical, neurobiological, and genetic correlates of First Episode Mania

IP: Silvia Amoretti Guadall
Collaborators: Miguel Angel Sandonis Vicente, Gemma Parramon Puig, Javimar Suarez Jesus
Funding agency: Fundació La Marató de TV3
Funding: 50049.25
Reference: 202234-32
Duration: 19/05/2023 - 18/05/2026

Grup consolidat

IP: José Antonio Ramos Quiroga
Collaborators: Pilar Lusilla Palacios, Natalia Calvo Piñero, Amanda Rodríguez Urrutia, Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Marc Ferrer Vinardell, Gemma Nieva Rifa, Mª Dolores Braquehais Conesa, Lara Grau Lopez, Constanza Daigre Blanco, Marta Ribases Haro, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Mireia Forner Puntonet, Christian Fadeuilhe Grau, Francisco Collazos Sanchez, Silvia Alemany Sierra, Silvia Amoretti Guadall, Gara Arteaga Henriquez, Natalia Llonga Tejedor, Maria Soler Artigas, Jorge Lugo Marin
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00840
Duration: 01/01/2022 - 30/06/2025

Beques Sara Borrell

IP: Marta Ribases Haro
Collaborators: Silvia Amoretti Guadall
Funding agency: Instituto de Salud Carlos III
Funding: 80598
Reference: CD20/00177
Duration: 11/01/2021 - 10/01/2024

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Inca Vilar Sastre

Inca Vilar Sastre

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Cristina Prat Vidal

Cristina Prat Vidal

Research assistant
Transfusional Medicine
Read more
Shilena Narci Rodriguez

Shilena Narci Rodriguez

Infectious Diseases
Read more
Marina Llanas Martinez

Marina Llanas Martinez

Predoctoral researcher
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.